Terms: = Colorectal cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
1552 results:
1. Precursor-Directed Biosynthesis of Neoantimycin Derivatives with Selective Cytotoxicity.
Li Z; Chai L; Tang Z; Zhu H; Xue P; Sun F; Lin H; Zhou Y; Lin X
J Nat Prod; 2024 May; 87(5):1376-1383. PubMed ID: 38662398
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a gene expression signature associated with brain metastasis in colorectal cancer.
Michl M; Taverna F; Woischke C; Li P; Klauschen F; Kirchner T; Heinemann V; von Bergwelt-Baildon M; Stahler A; Herold TM; Jurinovic V; Engel J; Kumbrink J; Neumann J
Clin Transl Oncol; 2024 Aug; 26(8):1886-1895. PubMed ID: 38558282
[TBL] [Abstract] [Full Text] [Related]
3. Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for colorectal Liver Metastases.
Laroche S; Scatton O; Charlotte F; Bachet JB; Lim C; Fuks D; Goumard C
Ann Surg Oncol; 2024 Jul; 31(7):4436-4444. PubMed ID: 38549003
[TBL] [Abstract] [Full Text] [Related]
4. Myotubularin-related-protein-7 inhibits mutant (G12V) k-ras by direct interaction.
Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
[TBL] [Abstract] [Full Text] [Related]
5. A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming k-ras mutations and drug resistance in colorectal carcinoma.
Song H; Li H; Shen X; Liu K; Feng H; Cui J; Wei W; Sun X; Fan Q; Bao W; Zhou H; Qian L; Nie H; Cheng X; Du Z
Acta Biomater; 2024 Mar; 177():456-471. PubMed ID: 38331131
[TBL] [Abstract] [Full Text] [Related]
6. Low colorectal cancer Risk After Resection of High-Risk Pedunculated Polyps.
Zorzi M; Battagello J; Amidei CB; Antonelli G; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rizzotto ER; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rugge M; ; Hassan C
Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1518-1527.e7. PubMed ID: 38325601
[TBL] [Abstract] [Full Text] [Related]
7. Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors.
Baranyi M; Molnár E; Hegedűs L; Gábriel Z; Petényi FG; Bordás F; Léner V; Ranđelović I; Cserepes M; Tóvári J; Hegedűs B; Tímár J
Br J Cancer; 2024 Apr; 130(6):1059-1072. PubMed ID: 38278976
[TBL] [Abstract] [Full Text] [Related]
8. Sotorasib Is a Pan-rasG12C Inhibitor Capable of Driving Clinical Response in NRASG12C cancers.
Rubinson DA; Tanaka N; Fece de la Cruz F; Kapner KS; Rosenthal MH; Norden BL; Barnes H; Ehnstrom S; Morales-Giron AA; Brais LK; Lemke CT; Aguirre AJ; Corcoran RB
Cancer Discov; 2024 May; 14(5):727-736. PubMed ID: 38236605
[TBL] [Abstract] [Full Text] [Related]
9. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
[TBL] [Abstract] [Full Text] [Related]
10. Targeted Mass Spectrometry Analyses of Somatic Mutations in colorectal cancer Specimens Using Differential Ion Mobility.
Wu Z; Bonneil É; Belford M; Boeser C; Dunyach JJ; Thibault P
J Proteome Res; 2024 Feb; 23(2):644-652. PubMed ID: 38153093
[TBL] [Abstract] [Full Text] [Related]
11. An Alternative to Cytology in Triaging Cisgender Men and Transgender Women With HIV for High-Resolution Anoscopy.
Mudrinich SM; Nguyen MLT; Blemur DM; Wang X; Wang YF; Krishnamurti U; Mosunjac M; Flowers LC
J Low Genit Tract Dis; 2024 Jan; 28(1):101-106. PubMed ID: 38117565
[TBL] [Abstract] [Full Text] [Related]
12. Surgeon-Dependent Variability in Cost of Gastrointestinal Operations in a Single cancer Center.
Sarkar J; Roehner RP; Proulx MJ; Schwarz RE
J Surg Res; 2024 Mar; 295():666-672. PubMed ID: 38113610
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive analysis of miRNA-mRNA regulatory pairs associated with colorectal cancer and the role in tumor immunity.
Liu C; Yu C; Song G; Fan X; Peng S; Zhang S; Zhou X; Zhang C; Geng X; Wang T; Cheng W; Zhu W
BMC Genomics; 2023 Nov; 24(1):724. PubMed ID: 38036953
[TBL] [Abstract] [Full Text] [Related]
14. Characteristic Mutational Damages in Gastric and colorectal Adenocarcinomas.
Yermekova S; Orazgaliyeva M; Goncharova T; Rakhimbekova F; Kaidarova D; Shatkovskaya O
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3939-3947. PubMed ID: 38019254
[TBL] [Abstract] [Full Text] [Related]
15. Oncologic relevance of genetic alterations in sporadic synchronous and solitary colorectal cancer: a retrospective multicenter study.
Son IT; Kim M; Oh BY; Kim MJ; Yoon SN; Park JH; Kim BC; Kim JW
BMC Gastroenterol; 2023 Sep; 23(1):297. PubMed ID: 37667167
[TBL] [Abstract] [Full Text] [Related]
16. Small molecular inhibitors for KRAS-mutant cancers.
Wu X; Song W; Cheng C; Liu Z; Li X; Cui Y; Gao Y; Li D
Front Immunol; 2023; 14():1223433. PubMed ID: 37662925
[TBL] [Abstract] [Full Text] [Related]
17. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human colorectal cancer Cells: Implications in Therapy.
Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE
Cells; 2023 Jun; 12(12):. PubMed ID: 37371096
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of
Lastraioli E; Bettiol A; Iorio J; Limatola E; Checcacci D; Parisi E; Bianchi C; Arcangeli A; Iannopollo M; Di Costanzo F; Di Lieto M
Cells; 2023 May; 12(11):. PubMed ID: 37296579
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study.
Goktas Aydin S; Kavak EE; Topcu A; Bayramgil A; Akgul F; Kahraman S; Aykan MB; Altıntas YE; Helvaci K; Urun Y; Bilici A; Seker M; Sendur MAN; Olmez OF; Acikgoz O; Cicin I
Biomol Biomed; 2023 Nov; 23(6):1089-1095. PubMed ID: 37289436
[TBL] [Abstract] [Full Text] [Related]
20. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
[TBL] [Abstract] [Full Text] [Related]
[Next]
